These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 34753904)

  • 1. Persistent astrocytic IL-3 stimulation of microglia slows disease in Alzheimer's: treatment perspectives for Alzheimer's.
    Haag N; Zempel H
    Signal Transduct Target Ther; 2021 Nov; 6(1):388. PubMed ID: 34753904
    [No Abstract]   [Full Text] [Related]  

  • 2. Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice.
    Yamamoto M; Kiyota T; Horiba M; Buescher JL; Walsh SM; Gendelman HE; Ikezu T
    Am J Pathol; 2007 Feb; 170(2):680-92. PubMed ID: 17255335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IKK2/NF-κB Activation in Astrocytes Reduces amyloid β Deposition: A Process Associated with Specific Microglia Polarization.
    Yang S; Magnutzki A; Alami NO; Lattke M; Hein TM; Scheller JS; Kröger C; Oswald F; Yilmazer-Hanke D; Wirth T; Baumann B
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal driven pre-plaque inflammation in a transgenic rat model of Alzheimer's disease.
    Hanzel CE; Pichet-Binette A; Pimentel LS; Iulita MF; Allard S; Ducatenzeiler A; Do Carmo S; Cuello AC
    Neurobiol Aging; 2014 Oct; 35(10):2249-62. PubMed ID: 24831823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy for Alzheimer's disease targeting CD33 reduces amyloid beta accumulation and neuroinflammation.
    Griciuc A; Federico AN; Natasan J; Forte AM; McGinty D; Nguyen H; Volak A; LeRoy S; Gandhi S; Lerner EP; Hudry E; Tanzi RE; Maguire CA
    Hum Mol Genet; 2020 Oct; 29(17):2920-2935. PubMed ID: 32803224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease.
    Meyer-Luehmann M; Spires-Jones TL; Prada C; Garcia-Alloza M; de Calignon A; Rozkalne A; Koenigsknecht-Talboo J; Holtzman DM; Bacskai BJ; Hyman BT
    Nature; 2008 Feb; 451(7179):720-4. PubMed ID: 18256671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hippocampal expression of murine IL-4 results in exacerbation of amyloid deposition.
    Chakrabarty P; Tianbai L; Herring A; Ceballos-Diaz C; Das P; Golde TE
    Mol Neurodegener; 2012 Jul; 7():36. PubMed ID: 22838967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monster plaques: what they tell us about Alzheimer's disease.
    Yankner BA
    Nat Med; 1998 Apr; 4(4):394-5. PubMed ID: 9546781
    [No Abstract]   [Full Text] [Related]  

  • 9. Commentary to: Differences between the pathogenesis of senile plaques and congophilic angiopathy in Alzheimer disease. (J Neuropathol Exp Neurol 1997; 56:751-61).
    Wisniewski HM; Frackowiak J
    J Neuropathol Exp Neurol; 1998 Jan; 57(1):96-8. PubMed ID: 9600200
    [No Abstract]   [Full Text] [Related]  

  • 10. Amyloid-β plaque reduction, endogenous antibody delivery and glial activation by brain-targeted, transcranial focused ultrasound.
    Jordão JF; Thévenot E; Markham-Coultes K; Scarcelli T; Weng YQ; Xhima K; O'Reilly M; Huang Y; McLaurin J; Hynynen K; Aubert I
    Exp Neurol; 2013 Oct; 248():16-29. PubMed ID: 23707300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perineuronal nets are largely unaffected in Alzheimer model Tg2576 mice.
    Morawski M; Pavlica S; Seeger G; Grosche J; Kouznetsova E; Schliebs R; Brückner G; Arendt T
    Neurobiol Aging; 2010 Jul; 31(7):1254-6. PubMed ID: 18829133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia/macrophage phenotype in amyloid precursor protein transgenic mice.
    Maier M; Peng Y; Jiang L; Seabrook TJ; Carroll MC; Lemere CA
    J Neurosci; 2008 Jun; 28(25):6333-41. PubMed ID: 18562603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse Model.
    Meilandt WJ; Ngu H; Gogineni A; Lalehzadeh G; Lee SH; Srinivasan K; Imperio J; Wu T; Weber M; Kruse AJ; Stark KL; Chan P; Kwong M; Modrusan Z; Friedman BA; Elstrott J; Foreman O; Easton A; Sheng M; Hansen DV
    J Neurosci; 2020 Feb; 40(9):1956-1974. PubMed ID: 31980586
    [No Abstract]   [Full Text] [Related]  

  • 14. Astrocytic gap junctional communication is reduced in amyloid-β-treated cultured astrocytes, but not in Alzheimer's disease transgenic mice.
    Cruz NF; Ball KK; Dienel GA
    ASN Neuro; 2010 Aug; 2(4):e00041. PubMed ID: 20730033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of activated astrocytes and of the neurotrophic cytokine S100B in the pathogenesis of Alzheimer's disease.
    Mrak RE; Griffinbc WS
    Neurobiol Aging; 2001; 22(6):915-22. PubMed ID: 11754999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE.
    Parhizkar S; Arzberger T; Brendel M; Kleinberger G; Deussing M; Focke C; Nuscher B; Xiong M; Ghasemigharagoz A; Katzmarski N; Krasemann S; Lichtenthaler SF; Müller SA; Colombo A; Monasor LS; Tahirovic S; Herms J; Willem M; Pettkus N; Butovsky O; Bartenstein P; Edbauer D; Rominger A; Ertürk A; Grathwohl SA; Neher JJ; Holtzman DM; Meyer-Luehmann M; Haass C
    Nat Neurosci; 2019 Feb; 22(2):191-204. PubMed ID: 30617257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microglia-Synapse Pathways: Promising Therapeutic Strategy for Alzheimer's Disease.
    Xie J; Wang H; Lin T; Bi B
    Biomed Res Int; 2017; 2017():2986460. PubMed ID: 28473983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of human S100B exacerbates cerebral amyloidosis and gliosis in the Tg2576 mouse model of Alzheimer's disease.
    Mori T; Koyama N; Arendash GW; Horikoshi-Sakuraba Y; Tan J; Town T
    Glia; 2010 Feb; 58(3):300-14. PubMed ID: 19705461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Cyanthin Diterpenoid and Sesterterpene Constituents of Hericium erinaceus Mycelium Ameliorate Alzheimer's Disease-Related Pathologies in APP/PS1 Transgenic Mice.
    Tzeng TT; Chen CC; Chen CC; Tsay HJ; Lee LY; Chen WP; Shen CC; Shiao YJ
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29463001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of REV-ERBs stimulates microglial amyloid-beta clearance and reduces amyloid plaque deposition in the 5XFAD mouse model of Alzheimer's disease.
    Lee J; Kim DE; Griffin P; Sheehan PW; Kim DH; Musiek ES; Yoon SY
    Aging Cell; 2020 Feb; 19(2):e13078. PubMed ID: 31800167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.